Effects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoprotein
about
Three-dimensional solution structure of the 44 kDa ectodomain of SIV gp41Evolution of the HIV-1 envelope glycoproteins with a disulfide bond between gp120 and gp41Efficient trapping of HIV-1 envelope protein by hetero-oligomerization with an N-helix chimera.Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus MacaquesStructural elucidation of critical residues involved in binding of human monoclonal antibodies to hepatitis C virus E2 envelope glycoproteinInhibition of human immunodeficiency virus type 1 infectivity by the gp41 core: role of a conserved hydrophobic cavity in membrane fusionStructural and functional analysis of interhelical interactions in the human immunodeficiency virus type 1 gp41 envelope glycoprotein by alanine-scanning mutagenesis.Discovery of Critical Residues for Viral Entry and Inhibition through Structural Insight of HIV-1 Fusion Inhibitor CP621-652Atomic structure of a thermostable subdomain of HIV-1 gp41Crystal structure of the simian immunodeficiency virus (SIV) gp41 core: conserved helical interactions underlie the broad inhibitory activity of gp41 peptidesPeptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infectionEvidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug targetCharacterization of siamycin I, a human immunodeficiency virus fusion inhibitorResistance to a drug blocking human immunodeficiency virus type 1 entry (RPR103611) is conferred by mutations in gp41Determinants of human immunodeficiency virus type 1 resistance to gp41-derived inhibitory peptides.A molecular clasp in the human immunodeficiency virus (HIV) type 1 TM protein determines the anti-HIV activity of gp41 derivatives: implication for viral fusionFunctional stability of unliganded envelope glycoprotein spikes among isolates of human immunodeficiency virus type 1 (HIV-1)Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41.Subdomain folding and biological activity of the core structure from human immunodeficiency virus type 1 gp41: implications for viral membrane fusion.A conserved tryptophan-rich motif in the membrane-proximal region of the human immunodeficiency virus type 1 gp41 ectodomain is important for Env-mediated fusion and virus infectivity.Role of the simian virus 5 fusion protein N-terminal coiled-coil domain in folding and promotion of membrane fusion.Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies.Human immunodeficiency virus (HIV) gp41 escape mutants: cross-resistance to peptide inhibitors of HIV fusion and altered receptor activation of gp120.Stoichiometry of antibody neutralization of human immunodeficiency virus type 1.Amino acid 36 in the human immunodeficiency virus type 1 gp41 ectodomain controls fusogenic activity: implications for the molecular mechanism of viral escape from a fusion inhibitorDissociation of the CD4 and CXCR4 binding properties of human immunodeficiency virus type 1 gp120 by deletion of the first putative alpha-helical conserved structure.Mutations in the leucine zipper-like heptad repeat sequence of human immunodeficiency virus type 1 gp41 dominantly interfere with wild-type virus infectivity.Stabilization of human immunodeficiency virus type 1 envelope glycoprotein trimers by disulfide bonds introduced into the gp41 glycoprotein ectodomainMutational analysis of residues in the coiled-coil domain of human immunodeficiency virus type 1 transmembrane protein gp41Structure-function studies of the self-assembly domain of the human immunodeficiency virus type 1 transmembrane protein gp41.Expanded host cell tropism and cytopathic properties of feline immunodeficiency virus strain PPR subsequent to passage through interleukin-2-independent T cellsModifications that stabilize human immunodeficiency virus envelope glycoprotein trimers in solution.Characterization of stable, soluble trimers containing complete ectodomains of human immunodeficiency virus type 1 envelope glycoproteins.Variable constraints on the principal immunodominant domain of the transmembrane glycoprotein of human immunodeficiency virus type 1.trans-dominant interference with human immunodeficiency virus type 1 replication and transmission in CD4(+) cells by an envelope double mutant.Determinants of CD4 independence for a human immunodeficiency virus type 1 variant map outside regions required for coreceptor specificity.Genetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development.Functional analysis of the disulfide-bonded loop/chain reversal region of human immunodeficiency virus type 1 gp41 reveals a critical role in gp120-gp41 association.Mutation-directed chemical cross-linking of human immunodeficiency virus type 1 gp41 oligomers.Conformational partitioning of the fusion peptide of HIV-1 gp41 and its structural analogs in bilayer membranes.
P2860
Q24533287-93306584-F3BD-48D2-A6EE-49928E463B82Q24802514-0732A5BF-E5C4-4CFA-93D7-0BFC11DEF6F0Q24811678-83DC65AD-2750-422E-943A-35F58081B1A2Q27318508-7DB4BB82-9E4A-49A0-8783-B27EA386A591Q27485636-ED7265B3-A144-421D-95C2-FA98DC3F377CQ27619600-CCE71291-03D7-41AF-9E2F-53C9AF4C2799Q27635422-59EC2744-FC0E-42FA-BB8D-B494658FDCECQ27678581-71FBC951-ECE0-484F-9C9A-5425831A1DB1Q27746904-351FF190-9E5F-4292-90BE-0D53ED772287Q27764897-6D854EA1-B859-49E6-8EFE-2900AAFD6EB7Q28369033-94B27582-0BC6-4995-B7E2-B45316B02DBFQ28369397-B60B32F4-4C4F-4722-A243-4BAC793BF233Q28379084-8C8667C8-BCD9-45CE-A57B-3D2BF298D8DCQ28379194-48F922EF-4666-4655-A19B-D958AC21B13CQ28379310-1EDD20AD-F661-44B0-9301-7AEB788728D3Q28646828-A21C9226-63C8-4784-8758-F4C128AD0E92Q28743199-88970136-883F-427A-9098-B2E9763E6010Q31016954-60D049F1-2022-42A7-9491-BE79AA39F5EDQ33648376-401107BC-6836-4C99-8F2F-E19934B1B99FQ33654081-74942DD3-02D1-4C67-A12B-8DD1F2D72CC0Q33717024-61D0A0F8-E9B0-49C6-8290-2D839FF89184Q33719511-0151045D-709B-47AE-95A2-FE475BCDC40EQ33724295-E356859F-681E-449D-B6D1-5FBE4E5CCAC6Q33737656-86BCC00B-0415-4A89-B558-81AB1550E333Q33780643-3E5D42E3-2805-4B2C-BB09-6A1C889E9008Q33783829-87E76984-31F0-4AB9-8C31-88CCF1000777Q33784040-C6F531F4-4F79-4487-9B64-E63A1B67422DQ33784051-B9B7A18A-8591-42A8-A023-2325251C87A9Q33785997-C00164C6-D028-4D3C-9D0F-DC45F3F50900Q33787186-39B8AA3E-F18D-4984-A147-06AC1CE1B716Q33797700-B1F18E95-7BE7-4ADE-B692-5F2DB5733B33Q33804811-4E09A77E-F7F4-4F9F-9DB2-D384635984CEQ33806056-C397AEA2-05FB-496F-9C10-E14141906554Q33815502-3D62C67E-638F-415B-B938-745D03595EB4Q33819782-498E6D7C-0F3F-43C9-B4B2-5D4ACF4B2787Q33825418-DA2AADE9-484D-4DCA-8183-F62F6B64B681Q33842152-F5A6228C-5829-4A04-9CA2-82DCF1A33056Q33843696-2D45F697-A468-4229-BE07-3721DB26F80DQ34070049-D65F2220-C440-4FAF-B0D3-24CE95050BCBQ34179319-58FD2084-2CC2-4907-8AA1-21F3317FF520
P2860
Effects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoprotein
description
1993 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի մայիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1993
@ast
im Mai 1993 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1993/05/01)
@sk
vědecký článek publikovaný v roce 1993
@cs
wetenschappelijk artikel (gepubliceerd op 1993/05/01)
@nl
наукова стаття, опублікована в травні 1993
@uk
مقالة علمية (نشرت في مايو 1993)
@ar
name
Effects of amino acid changes ...... e 1 gp41 envelope glycoprotein
@ast
Effects of amino acid changes ...... e 1 gp41 envelope glycoprotein
@en
Effects of amino acid changes ...... e 1 gp41 envelope glycoprotein
@nl
type
label
Effects of amino acid changes ...... e 1 gp41 envelope glycoprotein
@ast
Effects of amino acid changes ...... e 1 gp41 envelope glycoprotein
@en
Effects of amino acid changes ...... e 1 gp41 envelope glycoprotein
@nl
prefLabel
Effects of amino acid changes ...... e 1 gp41 envelope glycoprotein
@ast
Effects of amino acid changes ...... e 1 gp41 envelope glycoprotein
@en
Effects of amino acid changes ...... e 1 gp41 envelope glycoprotein
@nl
P2093
P2860
P1433
P1476
Effects of amino acid changes ...... e 1 gp41 envelope glycoprotein
@en
P2093
P2860
P304
P577
1993-05-01T00:00:00Z